Real-Time Oncology Review Excludes Applications Needing Adcomms Or New REMS

 
• By Sue Sutter
  
Starry sky
Revisions to the RTOR final guidance bring eligibility criteria more in line with those of the STAR program. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards